Sodium Butyrate Represses Cancer-Related Genes in Ovarian Carcinoma Cells
Author Information
Author(s): G Krupitzal, S Grill, H Harant, W Hulla, T Szekeres, H Huber, C Dittrich
Primary Institution: University of Vienna
Hypothesis
We wanted to investigate NaB-mediated interference on signals contributing to the expression of pradl, plau and gas6.
Conclusion
Sodium butyrate effectively down-regulates the expression of cancer-related genes in ovarian carcinoma cells.
Supporting Evidence
- Sodium butyrate treatment led to significant morphological changes in ovarian carcinoma cells.
- The expression of cyclin D1 and plasminogen activator-urokinase was suppressed by sodium butyrate.
- Fibronectin expression increased significantly in response to sodium butyrate treatment.
Takeaway
Sodium butyrate is a substance that can help stop cancer cells from growing by changing how certain genes work.
Methodology
N.1 ovarian carcinoma cells were treated with sodium butyrate, and gene expression was analyzed using Northern blotting.
Limitations
The effects of sodium butyrate on gene expression may not be specific and could vary with different conditions.
Want to read the original?
Access the complete publication on the publisher's website